NASDAQ:CRGX - US14179K1016 - Common Stock
The current stock price of CRGX is 4.47 USD. In the past month the price decreased by -1.11%. In the past year, price decreased by -75.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.87 | 371.68B | ||
AMGN | AMGEN INC | 13.19 | 154.89B | ||
GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
INSM | INSMED INC | N/A | 28.77B | ||
BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
NTRA | NATERA INC | N/A | 23.09B | ||
BIIB | BIOGEN INC | 8.26 | 19.38B |
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
CARGO THERAPEUTICS INC
835 Industrial Road, Suite 400
San Carlos CALIFORNIA US
Employees: 167
Phone: 16504998950
The current stock price of CRGX is 4.47 USD. The price decreased by -1.54% in the last trading session.
The exchange symbol of CARGO THERAPEUTICS INC is CRGX and it is listed on the Nasdaq exchange.
CRGX stock is listed on the Nasdaq exchange.
11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47. Check the CARGO THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CARGO THERAPEUTICS INC (CRGX) has a market capitalization of 216.17M USD. This makes CRGX a Micro Cap stock.
CARGO THERAPEUTICS INC (CRGX) currently has 167 employees.
CARGO THERAPEUTICS INC (CRGX) has a support level at 4.45 and a resistance level at 4.48. Check the full technical report for a detailed analysis of CRGX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CRGX does not pay a dividend.
CARGO THERAPEUTICS INC (CRGX) will report earnings on 2025-11-10.
CARGO THERAPEUTICS INC (CRGX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.66).
The outstanding short interest for CARGO THERAPEUTICS INC (CRGX) is 6.31% of its float. Check the ownership tab for more information on the CRGX short interest.
ChartMill assigns a technical rating of 1 / 10 to CRGX. When comparing the yearly performance of all stocks, CRGX is a bad performer in the overall market: 93.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to CRGX. CRGX has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -3.66. The EPS increased by 92.79% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -85.76% | ||
ROE | -93.3% | ||
Debt/Equity | 0 |
11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47.